Growth Metrics

Jazz Pharmaceuticals (JAZZ) Other financing activities (2016)

Jazz Pharmaceuticals (JAZZ) has 5 years of Other financing activities data on record, last reported at -$3.5 million in Q3 2016.

  • For Q3 2016, Other financing activities fell 994.69% year-over-year to -$3.5 million; the TTM value through Sep 2016 reached $320000.0, up 112.53%, while the annual FY2014 figure was $1.8 million, N/A changed from the prior year.
  • Other financing activities reached -$3.5 million in Q3 2016 per JAZZ's latest filing, up from -$4.4 million in the prior quarter.
  • Across five years, Other financing activities topped out at $10.6 million in Q1 2015 and bottomed at -$10.6 million in Q2 2015.
  • Average Other financing activities over 5 years is $741000.0, with a median of $320000.0 recorded in 2015.
  • Peak YoY movement for Other financing activities: surged 3903.66% in 2014, then tumbled 994.69% in 2016.
  • A 5-year view of Other financing activities shows it stood at $5.5 million in 2012, then plummeted by 98.51% to $82000.0 in 2013, then plummeted by 2824.39% to -$2.2 million in 2014, then soared by 114.32% to $320000.0 in 2015, then tumbled by 1194.69% to -$3.5 million in 2016.
  • Per Business Quant database, its latest 3 readings for Other financing activities were -$3.5 million in Q3 2016, -$4.4 million in Q2 2016, and $7.9 million in Q1 2016.